Acute liver failure is a rare and devastating clinical condition resulting from sudden loss of hepatic parenchyma and metabolic function. The Scottish Liver Transplant Unit (SLTU) offers specialist management and emergency liver transplantation to patients with acute liver failure from across Scotland.
SUMMARY Background
Acute liver failure is a rare and devastating clinical condition resulting from sudden loss of hepatic parenchyma and metabolic function. The Scottish Liver Transplant Unit (SLTU) offers specialist management and emergency liver transplantation to patients with acute liver failure from across Scotland.
Aim
To describe temporal changes in number of admissions, aetiology of acute liver failure, severity of disease at presentation and outcomes over a 22-year period.
Methods
Retrospective analysis of the SLTU database, including all patients admitted with acute liver injury or acute liver failure between November 1992 and March 2014.
Results
There has been no change in the number of patients presenting with acute liver injury or failure secondary to paracetamol overdose, but a reduction in the number of admissions with acute liver injury or failure secondary to non paracetamol causes. Over time, disease severity at presentation has not changed in the paracetamol cohort; those with a non paracetamol aetiology have latterly presented with milder hepatic encephalopathy. Spontaneous survival rates improved significantly over time for those patients with acute liver failure due to paracetamol and non paracetamol aetiologies. The most marked improvement in survival is observed in the sickest patients meeting Kings College Hospital poor prognostic criteria.
Conclusions
The number of admissions to the SLTU with acute liver failure is decreasing, due to reduced numbers of non paracetamol cases. Outcomes in this condition are improving, due to improvements in intensive care management and use of liver transplantation, and the increase in survival is most marked in patients meeting Kings College Hospital poor prognostic criteria. initially defined ALF as a severe liver injury which is potentially reversible in nature, with the onset of hepatic encephalopathy occurring within 8 weeks of the first symptoms, in the absence of pre-existing liver disease. In the Western world, ALF is estimated to affect fewer than 6.5 people per million population per year. 2, 3 The aetiology of ALF differs significantly worldwide. 4 Globally, viral infection accounts for the majority of cases of ALF, with mortality rates of greater than 50% still reported from the developing world. 5, 6 Paracetamol overdose (POD) is the leading cause of ALF in the UK 3, 7 (intentional overdose being the most common pattern 8 ) and the USA (accidental overdose reported as the most frequent overdose pattern 9 ). In 1998, UK introduced a sales restriction on paracetamol 10 after which some liver transplant units reported a decline in the absolute number of cases, 7, 11 and severity of disease at presentation. 7 Acute liver failure is a true clinical challenge to manage, in part due to its rarity and therefore lack of controlled clinical trials. Management strategies are based upon supportive intervention, and extrapolation from other critical illness. Previously, high mortality rates (>80%) for ALF were reported 7 independent of aetiology of disease. Emergency orthotopic liver transplantation became an accepted therapeutic modality for ALF in the late-1980s, 12 and now accounts for 8% of all liver transplants in Europe and the USA. 13, 14 . 17 Therefore, we are in a unique position to report data regarding ALF for a countries whole population, over an extended period of time. As all cases of ALF are cared for at this single institution, there are few confounders related to quality and type of care that these patients receive. The population of Scotland is stable, and temporal changes in Scotland are unaffected by development in transplant services and potential changes in referral practices as might influence data from the rest of the UK and other larger countries. We aim to describe our patient cohort in terms of evolution over time in patient demographics, aetiology of disease, severity of disease at presentation and outcomes. Data from our unit has been reported before, describing whole cohort statistics at a single time-point. In this study, we aim to update the description of our cohort and provide a further analysis based on changes over the last 22 years (the Scottish Look-Back Study).
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METHODS
Patients
This is a retrospective observational study performed over a period of 22 years, from the opening of the SLTU in November 1992 through to March 2014. All patients admitted to the SLTU with acute liver injury (ALI) and ALF during the study period were included. ALF was defined as the onset of coagulopathy (INR ≥1.5) with clinically overt hepatic encephalopathy, in the context of an acute liver insult of any kind. ALI was defined as an acute liver insult with coagulopathy (INR ≥1.5) in the absence of hepatic encephalopathy. Where possible, analyses were performed separately for patients with ALI and ALF. Patients who had evidence of chronic liver disease identified during investigation, or ALF secondary to hepatic trauma were excluded from the study. Data were obtained from the prospectively maintained SLTU database. Data collected included patient demographics, laboratory parameters in the referring hospital and on admission to the SLTU, aetiology of disease, need for admission to the Intensive Care Unit, renal replacement therapy or inotropic support, and outcome of admission to SLTU. Time from admission to referring hospital until transfer to the SLTU, and details of therapies administered in the referring hospital were not routinely available. With regard to laboratory parameters, we report prothrombin time rather than INR; as the data come from a single centre, the prothrombin time assay is standardised. Ammonia levels were not routinely checked and pH was not reliably recorded throughout the study period. Outcomes were described in four categories; spontaneous (i.e. transplant free) survival, survival with transplant, death without transplant and death with transplant. The primary outcome measure was spontaneous survival; survival was to 30 days. The original Kings College Hospital poor prognostic criteria (KCC) 18 were used to identify those patients unlikely to survive without transplantation, and if there were no medical or psychiatric contraindications, to list patients for emergency liver transplantation. Bernal later identified that arterial blood lactate quickly and accurately identified patients likely to die from POD-ALF. 19 The modified KCC, with the inclusion of arterial lactate increasing sensitivity and reducing the negative likelihood ratio, were proposed in 2002, 19 and subsequently adopted in our To assess trends over time, admissions were analysed in 3 or 5 year blocks. As 1992 and 2014 were not complete years for data collection (each containing only 2 months of data), for some analyses and graphical representations these years were excluded. Aetiology was broadly split into paracetamol overdose (POD) and other aetiologies (non-POD). For the purposes of data analysis, patients with a recorded 'unknown, seronegative, non A-non B hepatitis or non A-E hepatitis' aetiology were grouped with those with documented 'indeterminate ALF' following negative virological, immunological and where appropriate radiological/pathological investigations.
Management protocol in the SLTU
The management of patients with severe ALI and ALF admitted to the SLTU has not changed significantly over time. N-acetylcysteine was used routinely throughout the study period for patients admitted with a paracetamol overdose. N-acetylcysteine was not standard of care at any time-point for patients with a nonparacetamol aetiology. Patients were selected for intracranial pressure monitoring on the basis of clinical presentation. Extradural intracranial pressure monitoring was used in all cases, after correction of coagulopathy. Renal replacement therapy was indicated for renal dysfunction with oligo-anuria or for disorders of acid base balance. Intermittent haemodialysis was used at the beginning of the study period, with continuous veno-venous haemofiltration being the renal replacement method of choice for the majority of the time period analysed. All ventilated patients were treated with prophylactic broad spectrum antibiotics and anti-fungals. Therapeutic anti-microbials were otherwise used at the clinicians discretion. Liver support systems or plasmapheresis were not utilised during the study period.
Statistics
Data were anonymised prior to analysis. Data analysis was performed using SPSS (Version 19; SPSS Inc., Chicago, IL, USA) and GraphPad Prism (Version 7; GraphPad Software Inc., La Jolla, CA, USA). Results are expressed as median (AE inter-quartile range) and numbers (percentages) unless otherwise stated. Chi-squared and Fishers exact tests were used to analyse categorical data, and Kruskall-Wallis and Mann-Whitney U tests to analyse continuous data. A two sided P < 0.05 was considered statistically significant. Where the p value is not significant, this is recorded as P = N.S. Analysis of variance (ANOVA) with post hoc testing was used for trend analysis. Kaplan-Meier curves were created to perform survival analysis, and for some analyses, death/transplantation were considered equivalent in view of the previously reported high specificity of the KCC in this cohort.
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RESULTS
Temporal changes in number and aetiology of admissions Whole cohort analysis. During the study period (November 1992-March 2014) 1164 patients with ALI (n = 495) and ALF (n = 669) were admitted to the SLTU. 56% (n=652) were female, and the median age was 37 years (interquartile range 27-48 years). Paracetamol overdose (POD) was the most common reason for admission, accounting for 73.7% (n = 858) of all admissions. The number of admissions peaked in 1996-1998, with a gradual but significant decline in the total number of patients (all aetiologies) admitted per year group over time thereafter ( Figure 1 ; P < 0.001). There has been a significant decline in the number of transfers from some of the major referral centres in Scotland (Glasgow Royal Infirmary 1992-1996 n = 21; 2010-2014 n = 10: P < 0.0001. Ninewells Hospital, Dundee 1992-1996 n = 11; 2010-2014 n = 7: P < 0.001. Aberdeen Royal Infirmary 1992-1996 n = 15; 2010-2014 n = 14; P = N.S.).
Analysis by aetiology ( Table 1 ). The number of POD admissions peaked in 1996 and fell to a relatively stable number of admissions between 30 and 40 cases annually in the past 10 years ( Figure 1 ; P = N.S.). The number of non-POD admissions peaked in 2005-2007; this rise was accounted for by an increase in the number of cases of drug induced liver injury and ischaemic hepatitis. No one single drug was implicated in this rise in admissions with drug induced liver injury. Over the study period, there was a reduction in the numbers of patients admitted with indeterminate ALF, and beyond 2006 admissions with ischaemic hepatitis have become relatively rare (Table 1) . The number of patients presenting with ALI/ALF secondary to viral hepatitis fell over the study period. Hepatitis B (n = 18) and hepatitis E (n = 5) were the most commonly detected viruses. No cases of hepatitis A were seen after 1993, and conversely, no cases of hepatitis E were seen at the beginning of the study period. The number of cases of autoimmune hepatitis steadily increased over the years to peak in 2007-2011 (Table 1) . Admissions with ALI or ALF due to Budd-Chiari syndrome (n = 19) or malignant infiltration of the liver (n = 13) have remained stable over time.
Patients with acute liver failure ( Table 1) . In contrast, analysis of only patients with hepatic encephalopathy (i.e. ALF) shows that the absolute number of patients presenting with ALF over time has not significantly changed. There was also no significant difference in paracetamol or non paracetamol cases admitted over the time period of the study (Table 1) .
Temporal changes in severity of disease at presentation: (Table 2 ) On admission to the SLTU, the median hepatic encephalopathy grade for those patients presenting with encephalopathy was 1.0, with no significant change in the median grade of encephalopathy at presentation over time (Table 2 ). Although the percentage of patients with ALF presenting with deep (grade 3 or 4) hepatic encephalopathy has varied over time, there has been no change in the percentage of patients transferred to our unit intubated and ventilated (Table 2 ). An increasing percentage of patients admitted without encephalopathy subsequently developed this complication and therefore ALF ( Table 2) . Because of the significant differences in the evolution of the disease in paracetamol and non paracetamol cases of ALF, the analyses of disease severity at presentation are presented separately.
POD aetiology (Table 3) . Patients with POD have become significantly older over the study period (Table 3) . Regarding hepatic encephalopathy, no significant differences were observed in the percentage of patients developing this complication at any stage in their illness and there was no change in the severity of hepatic encephalopathy at presentation. A significant decline in median admission bilirubin and alanine aminotransferase over time was observed (Table 3) . Although median admission prothrombin time fluctuated, no clear temporal change was observed in creatinine (Table 3) .
Non-POD aetiology (Table 4 ). In the non-POD group, the age and sex distribution of the cases admitted has not Numbers expressed as median and IQR (interquartile range).
P value represents trend analysis.
Aliment Pharmacol Ther 2017; 45: 833-843changed over the study period (Table 4) . Regards hepatic encephalopathy, a significant change in the numbers of patients admitted with this complication was observed and the severity of hepatic encephalopathy at presentation has decreased over time. There was a significant reduction in median admission creatinine over time (Table 4) but none of the other blood analytes were affected.
Temporal changes in outcomes
Requirement for intensive therapy ( Figures S1 and  S2) . Overall, 49.8% (n = 580) of patients required admission to the Intensive Care Unit during the study period; this was more frequent in the POD cohort compared with the non-POD cohort ( Figure S1 ). An increased percentage of patients required mechanical ventilation and inotropic support over time ( Figure S2 ). Although 34.2% (n = 398) required a form of renal replacement therapy during their admission; over the study period, there was no significant change in the overall percentage of patients requiring renal replacement therapy ( Figure S2 ). Intracranial pressure monitoring was undertaken in 316 patients (55% of those admitted to intensive care); 83.5% (n = 264) had POD-ALF and 16.5% (n = 52) non-POD ALF. There was a trend towards a declining percentage of patients undergoing intracranial pressure monitoring over the study period ( Figure S2 ). In terms of treatment of raised intracranial pressure, data were only available for the use of thiopentone; use of this agent fell significantly over the study period (percentage of whole cohort receiving thiopentone 1992-1996 6.9%; 2012-2014 2.7%:
Survival outcomes: by presence of encephalopathy/ ALF. Overall survival rates have significantly increased from 53.6% in 1992-1996 to 74% in 2012-2014 (P = 0.013), including an increase in the percentage of patients surviving with transplantation (1992-1996 9.6%; 2012-2014 18.8%). However, when analysing the whole cohort there was no significant improvement in spontaneous survival during the study period ( Figure 2 ). In patients without hepatic encephalopathy, spontaneous survival rates remained greater than 95% throughout the whole study period. Spontaneous survival rates were significantly reduced in ALF cases (overall spontaneous survival rate of 36.6%) compared with patients with ALI (overall spontaneous survival rate of 98.8%; P < 0.001), but have improved significantly over time (1992) (1993) (1994) (1995) (1996) Comparing outcomes by year group of presentation, there was no significant difference in the percentage of patients spontaneously surviving between the 5 year subgroups of the study period (Figure 3 ; P = N.S.). On Cox regression analysis, year group of admission was not significantly associated with outcome, however, both age ALT = alanine aminotransferase (10-50 U/L).
Creatinine (64-111 lmol/L).
PT = prothrombin time (10.5-13.5 s).
Numbers expressed as median and IQR (interquartile range).
(P = 0.004) and meeting the KCC (P < 0.001) were significantly associated with outcome.
Survival outcomes: by aetiology. In terms of differences in outcome in relation to aetiology of disease, those with POD were significantly more likely to survive spontaneously compared with non-POD cases ( Figure 4) . Although there has been no improvement in spontaneous survival over time (1992) (1993) (1994) (1995) (1996) 68.1%; 2012-2014 68.8%: P = N.S.), there has been a significant increase in overall survival rates (1992-1996 75%; 2012-2014 85% P = 0.044), due to an increasing percentage of patients surviving with transplant (1992-1996 6.9%; 2012-2014 16.3%; P = 0.022) in the POD cohort. Across the whole study period, spontaneous survival rates for the non-POD cohort have remained lower than that of the POD cohort but there has been a trend towards an improvement in spontaneous survival rates in this cohort over time (1992) (1993) (1994) (1995) (1996) 33.3%; 2012-2014 55.7%; P = 0.085). In the non-POD cohort, overall survival rates have also significantly increased over time (1992) (1993) (1994) (1995) (1996) 54.8%; 2012-2014 80.9%; P = 0.046), without increased patients surviving with liver transplantation (1992-1996 21.4%; 2012-2014 28.6%; P = N.S.).
Temporal changes in outcomes for patients meeting KCC. Improvements in outcomes over time were significant and most striking in those sickest patients meeting the KCC (34.2% of whole cohort; n=398). In these patients, there were no spontaneous survivors during the first 10 years of the study period but spontaneous survival rates subsequently increased over the remainder of the study period ( Figure 5 ). This increase in spontaneous survival was observed in both the POD (1992-1996 0%; 2012-2014 14.3%; P < 0.001) and non-POD cohorts (1992-1996 0%; 2012-2014 12.5%; P = N.S.). Including transplant survival outcomes in this cohort with the most severe disease results in a substantial improvement in overall survival rates, with improvements in survival in both the POD and non-POD cohorts (Table 5) .
Addition of lactate to KCC. Arterial lactate criteria were introduced across UK in 2002 to identify poor prognosis in patients with ALF due to paracetamol overdose. For patients with POD-ALF, overall spontaneous survival with the original KCC was 45%, rising to 55% after the lactate modified KCC were introduced. Analysing only those patients who met the respective KCC, overall spontaneous survival with the original KCC was 0%, compared with 20% with the modified KCC (P < 0.001).
There was a trend towards a reduced percentage of patients meeting the KCC who went on to be transplanted between the original KCC (n = 38, 33.6%) and modified KCC (n = 42, 25.4%; P = 0.054).
Use of emergency liver transplantation. During the study period, 205 patients were considered transplant candidates (51.5% of the group meeting the KCC, 30.6% of the group with ALF, and 17.6% of the whole cohort). The most common reasons (more than one of which may have been present in the same patient) for patients not being considered as transplant candidates included: alcohol use disorders (n = 101), medical comorbidity/too sick to transplant (n = 81), active drug misuse (n = 26) and recurrent deliberate self-harm (n = 17). Over the study period, an increasing percentage of patients meeting KCC were considered to be suitable transplant candidates (1992-1996 53%; 2012-2014 66%: P = 0.005) and there has been a significant increase in the percentage of patients meeting KCC who have survived from listing to receive an emergency liver transplant (1992-1996, 36.4%; 2012-2014, 55.6%: P < 0.001). Similar improvements in outcomes were observed when analysing POD and non-POD cohorts separately. A total of 160 patients underwent emergency OLT during the study period (POD n = 80, non-POD n = 80). Of those patients transplanted, 79% (n = 127) were discharged alive. The percent of patients surviving with transplant increased over the study period; overall rates of survival with transplant were equivalent for the non-POD cohort (50.4%) compared with the POD cohort (49.6%).
DISCUSSION
This is the first study from our unit to report detailed temporal analysis relating to acute liver injury and failure (ALI/ALF) over approximately 22 years. Our unit is unique in that we have a comprehensive, prospectively maintained database detailing all patients admitted with ALI and ALF, and therefore, we are in a unique position to describe experience in presentation and management of this rare condition in a tertiary referral centre covering a single country with a stable population. Our referral criteria have changed little over the study period and therefore these data most likely reflect true changes in disease characteristics rather than a change in referral patterns and development in transplant services over time. However, some patients from other centres in Scotland are not transferred to our unit for a number of reasons including medical and psychiatric contraindications to transplant or the patient being too sick to transfer. 23 Therefore, the cohort described is subject to uncontrollable selection and referral bias. Nevertheless, in our analysis of trends over time we have identified a significant reduction in the number of cases admitted to our unit, changes in the frequency of individual causes of ALF and considerable improvements in patient survival despite relatively little alteration in markers of disease severity.
In Scotland, the relative frequencies of individual causes of ALF have changed between 1992 and 2014. We have observed a reduction in cases admitted with viral hepatitis in common with other published data. 7, 16 Our overall number of SLTU admissions with viral hepatitis (2.23%) is lower than that reported by others 7, 24 reflecting the different demographic make-up of these referral populations. The reduction in admissions with viral hepatitis may be related to public health measures, for example the introduction of a combined hepatitis A and B vaccine (Twinrix) in 1997 and improved sanitation (also applicable in other Western countries). These data contrast with experience of hepatitis E infection. Some patients previously labelled as having indeterminate ALF 25 or drug induced liver injury 26 may have had undetected acute hepatitis E infection as the possibility of infection with this virus was not recognised, and the means for testing was not available in the earlier years of our cohort study. These data reinforce the need for a high level of suspicion for hepatitis E in those presenting with ALI, and testing for hepatitis E should now be considered routine in the investigation of such patients. We have also observed a reduction in the number of admissions with indeterminate ALF. This may be related to improvements in other diagnostic capabilities. The ALFSG also report a trend towards a declining number of admissions with indeterminate ALF 16 with the number of cases true of 'indeterminate ALF' falling after expert review. 27 The ALFSG also report an increase in the number of admissions with ischaemic hepatitis 16 ; in contrast we have observed an opposite trend. There have been conflicting results from studies looking at the impact on paracetamol related admissions following the introduction of a sales restriction in the UK on paracetamol in 1998. 28 16 Furthermore, no change in the severity of disease at presentation for those presenting with paracetamol induced acute liver injury or failure was observed during this cohort study. This contrasts with the observed reduced INR reported from the Kings College unit. 7 Prince 11 reported no change in severity of POD as assessed by overdose size, substance taken or criteria for transplant but a systematic review reported no effect of the legislation on the severity of paracetamol poisoning in the UK. 28 Studies reporting outcomes in ALF 3, 7, 9, 16 have shown that although this disease was previously considered to be universally fatal, outcomes have significantly improved over time. Most recently, and consistent with our findings, the ALFSG reported improved overall, post-transplantation and transplant-free survival. 16 Such improvements in outcome are multifactorial and likely reflect a better understanding of the disease process and its potentially fatal complications such as cerebral oedema, as well as timely referral from secondary care centres, improvements in medical and intensive care management and increasing use of emergency liver transplantation. Both groups also report a significant increase in spontaneous survival. 7, 16 Of note, the Kings College cohort was most similar to ours in that it included patients with ALI and ALF, whereas the ALFSG cohort included patients with ALF only. In our whole cohort, we report no significant improvement in the percentage of patients spontaneously surviving, in contrast with these other studies. However, excellent survival was observed in patients with ALI that never develop hepatic encephalopathy and will confound analysis of spontaneous survival in the whole cohort. Limiting analysis of spontaneous survival to cases with encephalopathy reveals significantly improved survival in patients with admitted to the SLTU with ALF. Of most importance and clinical relevance is the improvement, we report in the outcomes for the group of patients who meet poor prognostic criteria (Kings College Criteria, KCC) which are used in the UK to identify those patients who are unlikely to survive without emergency liver transplantation. 22, 30, 31 The reason for improved survival in these very sick cases relates to improved spontaneous survival and survival to transplantation, and not any change in the relative numbers of patients considered to have contraindications to emergency transplantation. Arterial lactate was incorporated into the KCC for POD-ALF in 2002. 19 This had no effect on outcomes for paracetamol induced ALF in the Scottish cohort. Furthermore, a recent systematic review has called into question the benefit of lactate modifications to the KCC 22 resulting in recent modification of the arterial lactate criteria.
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Limitations This is a retrospective observational study interrogating a prospectively collected database. Some data were not available despite review of paper and electronic notes where available, and although the number of missing data was minimal, this is a limitation of any retrospective study. In addition, we accept that not all patients with ALF in Scotland are admitted and managed in the SLTU, and patients may not be discussed with our unit for a number of reasons, including co-morbidity status, and as such our data will be subject to uncontrollable selection and referral bias.
CONCLUSIONS
There has been a decrease in the total number of admissions with ALI and ALF to the SLTU over a 22-year period. For our whole cohort, spontaneous survival rates have not changed over time, however, spontaneous survival has improved in patients with ALF compared with ALI. Improvements in medical and intensive care management, and the role of emergency liver transplantation as therapy have significantly improved survival in the sickest individuals who meet poor prognostic criteria. Additional longterm studies of changes in aetiology and outcomes of ALF from other liver transplant units would be extremely useful, to help direct further research and guide service provision and development for this rare and devastating disease.
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